If that were possible, that would actually make sense because, as we have found out, the real benefit of Vascepa is not the lowering of triglycerides. As we have learned, lowering triglycerides by itself does not provide that much benefit. I don’t believe the FDA would go so far as to withdraw the approval. It is a shame there isn’t something to distinguish Marine Vascepa from Reduce-It Vascepa.